Scm Lifescience Was Established In 2014 With The Vision Ofdeveloping Treatment Options For Difficult To Treat Diseases To Provide A New Source Of Hope For Patients And Contribute To The Welfare Of Humanity As A Whole Aeusing Proprietary Stem Cell Isolation Technology And Stem Cell Production Technology Through Over 10 Years Of R&Dscm Lifescience Has Obtained Intellectual Property Protection For Its High Purity Stem Cell Isolation Technology Registered Patent In Korea 2008 Us 2010 Japan 2012 China 2013 And Eu 2014 And High Purity Stem Cell Production Technology Us Registered Patent 2014Based On These Technical Breakthroughshigh Purity Stem Cell Therapy Shall Be Provided To Treat Various Immunological Conditions Such As Graft Versus Host Disease Gvhd Atopic Dermatitisacute Pancreatitisdiabetesand Asthmaour Research Will Also Focus On The Field Of Regenerative Medicine For Technological Breakthroughs Including The Regeneration Of Skincartilagebone And Other Various Tissues And Organs Scm Lifescience Aims To Contribute To The Advancement Of The Stem Cell Sector Through Its Various Business Areas Including High Purity Stem Cell Storagelarge Volume Culture Of Stem Cell For Investigative Purposesand Stem Cell Research With Our Proprietary Technologyscm Will Continue To Pursue Excellence In The Fields Of Stem Cell And Regenerative Medicine To Become An Internationally Recognized Leader In These Fields
No conferences found for this company.
| Company Name | Scm Lifescience Co Ltd |
| Country |
South Korea
|
| Address | N/A |
| Telephone | N/A |
| N/A |
